N-of-One's solutions have provided therapeutic options, including clinical trials, for tens of thousands of patient cases across hundreds of cancer types.
Founders
Christine M. Cournoyer
Company Description
N-Of-One analyzes and interprets tumor molecular profiles to help physicians and patients identify diagnostic and treatment strategies.